2025 annual financial data
Madrigal Pharmaceuticals 2025 Operating margin
Madrigal Pharmaceuticals 2025 operating margin with verified reported values.
Direct answer
Operating margin was -31.31%.
Operating income was -300,097,000 USD and net income was -288,284,000 USD.
Operating cash flow was -189,553,000 USD.
Get free Madrigal Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 958,403,000 USD
- Operating income
- -300,097,000 USD
- Net income
- -288,284,000 USD
- Operating cash flow
- -189,553,000 USD